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Background: Surveillance of healthcare-associated 
infections (HAI) is the basis of each infection con-
trol programme and, in case of acute care hospitals, 
should ideally include all hospital wards, medical spe-
cialties as well as all types of HAI. Traditional surveil-
lance is labour intensive and electronically assisted 
surveillance systems (EASS) hold the promise to 
increase efficiency. Objectives: To give insight in the 
performance characteristics of different approaches to 
EASS and the quality of the studies designed to evalu-
ate them. Methods: In this systematic review, online 
databases were searched and studies that compared 
an EASS with a traditional surveillance method were 
included. Two different indicators were extracted 
from each study, one regarding the quality of design 
(including reporting efficiency) and one based on the 
performance (e.g. specificity and sensitivity) of the 
EASS presented. Results: A total of 78 studies were 
included. The majority of EASS (n = 72) consisted of 
an algorithm-based selection step followed by con-
firmatory assessment. The algorithms used differ-
ent sets of variables. Only a minority (n = 7) of EASS 
were hospital-wide and designed to detect all types 
of HAI. Sensitivity of EASS was generally high (> 0.8), 
but specificity varied (0.37–1). Less than 20% (n = 14) 
of the studies presented data on the efficiency gains 
achieved. Conclusions: Electronically assisted surveil-
lance of HAI has yet to reach a mature stage and to be 
used routinely in healthcare settings. We recommend 
that future studies on the development and implemen-
tation of EASS of HAI focus on thorough validation, 
reproducibility, standardised datasets and detailed 
information on efficiency.
Introduction
Surveillance of healthcare-associated infections (HAI) 
entails the systematic collection of data on the pres-
ence of HAI, analysis and transformation of the data 
into information and sharing this information with 
those who can take action to prevent HAI. Surveillance 
with feedback is a key/core component for effective 
infection prevention and control in the strategies of 
both the World Health Organization (WHO) and the 
European Centre for Disease Prevention and Control 
(ECDC) [1,2]. Surveillance and epidemiology are the 
first criteria included in the minimum standard of 
practice of an infection preventionist (Association for 
Professionals in Infection Control and Epidemiology 
(APIC) 2016 professional and practice standards). They 
are also a core task according to the Dutch society of 
Hygiene and Prevention in Healthcare (VHIG 2014, pro-
fessional profile). The Health and Social Care Act 2008 
code of practice of the prevention and control of infec-
tions and related guidance (2015, United Kingdom) 
likewise states that there should be evidence of local 
surveillance and of the use of comparative data, where 
available, to monitor infection rates in healthcare set-
tings. In 2005, legislation on mandatory reporting of 
HAI had already been enacted in 35 states of the United 
States. In 2008, the Centers for Medicare and Medicaid 
Services stopped additional payment to hospitals to 
cover for the costs of treating mediastinitis after coro-
nary artery bypass graft surgery, because this HAI was 
deemed to be preventable by HAI surveillance and con-
trol. Likewise, surgical site infection (SSI) after specific 
orthopaedic procedures and bariatric surgery were not 
covered anymore. This change reflected the impor-
tance of HAI surveillance and prevention. Hospital 
accrediting authorities, including Joint Commission 
International, also recognise the importance of surveil-
lance activities.
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Surveillance in its traditional format, in which every 
patient’s record is assessed on the presence of HAI, 
is labour intensive and can take up to 756 manhours 
for a point prevalence survey or an estimated 1.5 full-
time equivalent (FTE) per 10,000 admissions [3,4]. 
Surveillance of HAI should ideally include all hospital 
wards, medical specialties as well as all types of HAI, 
such that fully informed, evidence-based decisions 
can be made to prioritise and structurally address 
the relevant infection issues of the particular health-
care setting. However, in the face of limited resources, 
available labour intensive manual surveillance systems 
have driven most healthcare centres to apply so-called 
targeted forms of surveillance that include only high 
risk wards and/or few types of medical procedures 
and/or only a few types of HAI.
Alternatively, efforts have been made to significantly 
improve the efficiency (i.e. reducing the time spent on 
surveillance while obtaining the same results) of HAI 
surveillance by applying information technologies to 
query data routinely available in hospital electronic 
databases. With the ongoing application of new infor-
mation technologies in healthcare, the types and sizes 
of these electronic databases have been increasing 
over the last decades. It is, however, unclear what level 
of efficiency and accuracy (i.e. proportion of individu-
als truly positive and negative for an HAI) has been 
attained so far by applying these newer electronic 
information sources and technologies. Increasing the 
efficiency of surveillance can be achieved by introduc-
ing a computerised algorithm-based selection of high-
risk patients followed by confirmatory assessment of 
the selected cases by the infection control practitioner 
(ICP) (semi-automated electronically assisted surveil-
lance system (EASS)). Alternatively, surveillance can 
be based on the outcome of a computerised algorithm 
alone, without confirmation of individual cases by the 
ICP (fully automated EASS).
With this systematic review, we aim to give insight 
in the current status of EASS by assessing their per-
formance (sensitivity and specificity) compared with 
traditional surveillance, the variables used in the elec-
tronic algorithms and the quality of the studies (includ-
ing efficiency) that presented and evaluated them.
Methods
Inclusion of articles
In this systematic review, the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines were followed [5]. The following online data-
bases were searched on 10 January 2018: Embase, 
Medline Ovid, Cochrane, Web of Science, Scopus, 
CINAHL (EBSCOhost) and Google Scholar. The Embase 
search was the basis for the search method and then 
translated for use in other databases. All publications, 
except grey literature, in the past up to 10 January 2018 
were included. The full description of the queries per 
database is provided in the  supplementary material. 
The process of identification, screening and inclusion 
of articles for full text synthesis is consistent with the 
method described by Bramer et al. [6-8]. In brief, this 
method consists of a query in online databases, review 
of all the abstracts by two reviewers independently to 
screen for articles that probably meet the inclusion cri-
teria (eligible) followed by full article review to decide 
whether an article is included based on the inclusion 
and exclusion criteria. Included were studies which sys-
tematically evaluated the performance of an electroni-
cally assisted or fully automated surveillance method 
against the gold standard (expert opinion of the ICPs 
based on the United States Centers for Disease Control 
and Prevention-based criteria for HAI [9]), and reported 
at least one performance metric (e.g. sensitivity, speci-
ficity). Exclusion criteria were potential incorporation 
bias, non-English language studies and poster or con-
ference abstracts.
Data collection process
Using a standardised format, we abstracted the fol-
lowing reported information from each study: (i) year 
of publication, country and setting; (ii) the study type, 
population characteristics and sample size; (iii) the 
type of HAI (bloodstream infections (BSIs), lower res-
piratory tract infections (LRTIs), SSIs or urinary tract 
infections (UTIs)) targeted for surveillance, likewise the 
medical specialties or wards that were participating in 
the surveillance effort; (iv) the sensitivity, specificity, 
positive and negative predictive value, accuracy of the 
EASS; and (v) all variables that were used in their algo-
rithms. Missing information was not checked with the 
authors.
Table 1
Categorisation of the electronically assisted surveillance system’s algorithms based on the set of variables included
Category Description
1 ICD coding only
2 Microbiology (bacterial, viral, fungal pathogens detected by culture, molecular or serological diagnostics)
3 Microbiology + antibiotic prescriptions
4 Microbiology + antibiotic prescriptions + clinical chemistry
5 Other (body temperature OR/AND judgement by physician OR/AND ventilator setting OR/AND fuzzy logic or natural language processing of clinical notes OR/AND risk factors, like indwelling catheters)
ICD: International Classification of Diseases.
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Algorithm categories
For each study, we assigned the respective algorithm 
used to one of the categories based on the variables 
included as presented in Table 1.
Overall quality and performance score
Two different scores were calculated based on the data 
extracted from each study, one regarding the reported 
design of the study and one regarding the performance 
of the EASS presented. First, to assess the quality of 
the design we scored six indicators that represent dif-
ferent aspects of the design of the study. As an exam-
ple, for indicator 1, the rationale was as follows: an 
EASS should be evaluated in a set of patients that is 
independent of the set used to develop the automated 
method, as recommended by Govindan et al. in 2010 
[10]. Thus when the study population consisted of a 
validation cohort and a separate development cohort 
this was considered better (5 points) than when the 
study population consisted of a development cohort 
only (1 point). Subsequently we calculated an overall 
quality score by adding up the points assigned for each 
of the six quality indicators presented in Table 2.
Secondly, for each study we calculated an overall per-
formance score of the EASS presented in the study by 
multiplying its published sensitivity and specificity. 
This overall performance score is primarily based on 
the sensitivity and specificity to detect all types of HAI. 
If not all types of HAI were included we calculated an 
overall performance score based on the means of the 
sensitivities and specificities specified for the types of 
HAI that were included in the study.
Ethical statement
Ethical approval was not applicable for this review of 
published literature.
Results
The online databases search identified 2,410 records 
after de-duplication, of which 78 studies [3,4,11-86] 
were included in this systematic review (Figure 1). 
Timeline and geographical distribution
Of the 78 identified studies, 30 were from Europe, six 
from Asia, one from South America and the remaining 
41 from North America. The first articles about EASS 
of HAI originated in North America and were published 
in the 1980s and 1990s. Thereafter, their number 
increased gradually, involving European centres since 
the turn of the century, and, more recently centres in 
Table 2
Quality of study designs: indicators used to evaluate the level of quality of study designs investigating an electronically 
assisted surveillance system
Indicator – description Points awarded
Indicator 1 – validation and test cohort
       The study population consisted of a validation cohort and a separate development cohort 5
       The study population consisted of a validation cohort 3
       The study population consisted of a development cohort only 1
Indicator 2 – reported context of study
       The observed prevalence or incidence of HAI in the healthcare institute was presented in the article 5
       Prevalence or incidence of HAI was not presented in the article 0
Indicator 3 – departments under surveillance for HAI
       EASS was hospital-wide and included all wards or departments 5
       EASS was not hospital-wide but included > 2 departments or wards 3
       EASS was targeted to one department or ward only 1
Indicator 4 – types of HAI under surveillance
       EASS targeted all types of HAI 5
       EASS targeted > 2 types of HAI 3
       EASS targeted one or two types of HAI only 1
Indicator 5 – performance characteristics reported
       Sensitivity, specificity and other performance characteristics of the EASS algorithm were presented 5
       Only sensitivity and specificity were presented 3
       Only sensitivity was presented 1
Indicator 6 – efficiency reported
       Time reduction was presented quantitatively 5
       Workload reduction was presented 3
       No data on workload or time reduction presented 1
HAI: healthcare-associated infection; EASS: electronically assisted surveillance system.
The red colour represents poor quality, the orange intermediate quality and green indicates good quality.
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other parts of the world; a peak in the annual number 
of published articles was reached in 2014 (Figure 2).
In the earliest identified study, in 1986, Evans et al. [30] 
presented the results of HAI surveillance through their 
Health Evaluation through Logical Processing (HELP) 
system at the Latter Day Saints hospital, Salt Lake City, 
Utah. These pioneers showed that more HAI were found 
with this EASS, while its execution required only 35% 
of the time. In follow-up studies HELP was used to eval-
uate algorithms to predict infections even before onset 
of symptoms [29]. It was not until the year 2003 that 
the first European study was published describing the 
performance of an EASS; this EASS was implemented 
in 1998 in a university affiliated teaching hospi-
tal in France [11]. From 2000 to 2009 predominantly 
American and European research groups presented 
their EASS in the international peer-reviewed litera-
ture. In the year 2006, Brossette et al. [4] published the 
first results of their EASS that used a laboratory-based 
algorithm, called Nosocomial Infection Marker (NIM), 
to help identify patients with HAI. This software was 
the first to become commercially available. From 2010 
on, the numbers of publications increased and peaked 
in 2014. Contributions originating from South America 
[56] and Asia [3,24,50,67,68,77] showed that by that 
time EASS of HAI had adopters worldwide.
Fully- vs semi-automated surveillance
Only six of the 78 studies (8%) present a fully auto-
mated surveillance method [20,27,52,62,65,69], with 
sensitivities ranging from 0.6 to 0.94 for UTIs and ven-
tricular drain infections respectively.
Quality
As for indicator 1 of the overall quality score (Table 
2), 18 of the 78 (23%) articles included in this review 
used a development and separate validation cohort. 
The majority of articles (53 of 78) clearly presented the 
point prevalence or incidence of the HAI in the popula-
tion they studied (quality indicator 2, Table 2). The EASS 
was hospital-wide (maximum points for quality indica-
tor 3, Table 2) and included all types of HAI (maximum 
points for quality indicator 4, Table 2 with at least the 
‘big four’ types of HAI, i.e. BSIs, LRTIs, UTIs and SSIs) 
in nine of the 78 studies. Just under 40% (31/78) of the 
studies presented performance characteristics other 
than only sensitivity and specificity (maximum points 
for indicator 5). Less than 20% (14/78) of the studies 
presented the actual time reduction that was achieved 
by introducing an EASS for HAI (maximum points for 
Figure 1
A flowchart of the inclusion process of studies used in the systematic review (adjusted from the PRISMA 2009 flowchart)
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185 studies were not included based on the full 
text review:
Not meeting inclusion criteria (n = 95):
• No performance metrics reported (n = 84)
• No gold standard defined (n = 11)
 Meeting exclusion criteria (n = 58):
• Potential incorporation bias (n = 4)
• Proceedings/meeting abstracts errata/commen-
tary/to the editor (n = 54)
Miscellaneous (double included/full text not 
found/miscellaneous (n = 32)
Articles excluded after two independent reviewers 
screened all the abstracts and discrepancies were 
resolved by consensus (n = 2,147)
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
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indicator 6, Table 2). None of the articles attained the 
maximum score (all six indicators ‘green or maximum 
points appointed’) and, interestingly, the overall qual-
ity score did not seem to improve over the years (sup-
plementary material Table 1).
Performance of electronically assisted 
surveillance systems per type of healthcare-
associated infection
EASS were most extensively developed and applied 
in intensive care unit (ICU) settings (44 of the 78 arti-
cles included in this review); 20 articles describe an 
EASS that was developed exclusively for the ICU and 
targeted the ICU’s two most common HAI (ventilator 
associated pneumonia (VAP) and central line associ-
ated BSIs (CLABSI)) [15,18,27,28,32,33,38,40,42,43,51,
52,55,57,61,62,73,75,78,81]. Other studies focused on 
one particular type of HAI (one or more of the ‘big four’: 
LRTIs, BSIs, SSIs and UTIs) and aimed to facilitate its 
detection and registration hospital-wide [3,4,13,21,23-
25,29,30,50,58,59,63,66-68,74,79,80,83,86]. Among 
these a few research groups tried to develop the ‘one 
algorithm to find them all’ [3,4,21,23,24,29,30], i.e. 
one algorithm that can be used to detect all types of 
HAI in all departments and medical specialties. The 
studies that aimed to achieve this, present sensitivi-
ties ranging from 0.78 to 0.99. Du et al. [3] describe 
an excellently performing algorithm (sensitivity 0.99, 
specificity 0.93) to detect HAI in real time. Interestingly, 
they presented a decision support system to aid the ICP 
professional in making the final ‘HAI present or not’- 
decision. Doing so, they claim to have increased the 
overall specificity of their surveillance system to 0.99. 
A downside to their approach was a decrease of sensi-
tivity to 0.94. This was due to the fact that the informa-
tion provided by the support software was sometimes 
not sufficient for final confirmation of the presence of 
a HAI or no HAI.
Algorithms and parameters used in 
electronically assisted surveillance system
In their review ‘Surveillance and use of computers in 
hospital infection control’ Wenzel and Streed [87] pre-
sented a timeline of the evolution of surveillance of 
infectious diseases including healthcare-associated 
ones, from 1532 to 1989, pointing out key figures and 
events in its history. As they elaborated on the differ-
ent elements of surveillance, the authors eventually 
addressed how the application of computers could 
help infection control with their surveillance activi-
ties and add to their accuracy and probably to effi-
ciency as well. In 2002 Peterson and Brossette [88] 
addressed the importance of clinical microbiological 
laboratories and the clinical microbiologist in HAI con-
trol. They stated that laboratory-based surveillance 
has the advantage of measuring hospital-wide occur-
rences from a single, central data collection point. 
These microbiological data could be used in a hospital-
wide EASS of HAI. In 2008, Leal et al. [89] reviewed 24 
articles in which microbiological data constituted the 
predominant variable used in electronic surveillance 
systems for HAI. Among those reviewed by Leal et al., 
six studies reported that HAI could be detected using 
microbiology data alone with reasonable to good over-
all sensitivity (range: 0.63–0.91) and excellent specific-
ity (range: 0.87 to > 0.99). According to the Leal et al. 
review, seven studies using only administrative data 
including discharge coding (International Classification 
of Diseases (ICD), 9th edition, Clinical Modification) 
and pharmacy data reported good sensitivity (range: 
0.59–0.96) and excellent specificity (range: 0.95 
to > 0.99) in detecting HAI. Moreover, six studies using 
both laboratory and administrative data reported a 
higher sensitivity (range: 0.71–0.94) but lower speci-
ficity (range: 0.47 to > 0.99) compared with the use of 
either alone. In 2013, Freeman et al. [90] performed a 
systematic review in which they categorised the EASS 
in multisource (including microbiological data) (n = 37), 
multisource (excluding microbiological data) (n = 4) 
and single source systems (n = 3). Of these 44 articles 
included for review, 21 were validation studies. There 
was no difference in the performance of multisource 
systems excluding or including microbiology. Of note, 
the single source validation studies, used natural lan-
guage processing techniques to extract information 
from the radiology reports and electronic health record 
to detect LRTI and BSI respectively [33,91]. Based on 
the results of their review in 2014 de Bruin et al. [92] 
concluded that driven by the increased availability of 
electronic patient data, EASS tend to use more data 
sources. This is making systems more sensitive yet 
less specific, but also allows systems to be tailored 
to the needs of healthcare institutes’ surveillance pro-
grammes. The findings of Cato’s review [93], in 2015, 
suggest that the majority of EASS for HAI surveillance 
are using standard definitions of HAI, but the lack of 
standardised use of data formats, denominator, and 
external validation in these systems reduces the reli-
ability of their findings.
Figure 2
Published studies on electronically assisted surveillance of 
healthcare-associated infections by year of publication and 
by region of the world (n = 78)
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Figure 3
Sensitivity of electronically assisted surveillance systems by category of algorithm used and by type of healthcare-associated 
infection (n = 78)
HA
I to
tal BS
I
LR
TI UT
I
SS
I 
0
20
40
60
80
100
Type of HAI
Se
ns
iti
vi
ty
 (%
)
Category 1
HA
I to
tal BS
I
LR
TI UT
I
SS
I
 
0
20
40
60
80
100
Type of HAI
Se
ns
iti
vi
ty
 (%
)
Category 4
HA
I to
tal BS
I
LR
TI UT
I
SS
I 
0
20
40
60
80
100
Type of HAI
Se
ns
iti
vi
ty
 (%
)
Category 2
HA
I to
tal BS
I
LR
TI UT
I
SS
I
 
0
20
40
60
80
100
Type of HAI
Se
ns
iti
vi
ty
 (%
)
Category 5
HA
I to
tal BS
I
LR
TI UT
I
SS
I 
0
20
40
60
80
100
Type of HAI
Se
ns
iti
vi
ty
 (%
)
Category 3
Average
Single study 
BSI: bloodstream infections; HAI: healthcare-associated infection; LRTI: lower respiratory tract infections; SSI: surgical site infections; UTI: 
urinary tract infections.
Category 1: international classification of diseases coding only; category 2: microbiology (bacterial, viral, fungal pathogens detected by 
culture, molecular or serological diagnostics); category 3: microbiology + antibiotic prescriptions; category 4: microbiology + antibiotic 
prescriptions + clinical chemistry; category 5: other types of algorithms (using parameters like body temperature OR/AND judgement by 
physician OR/AND ventilator setting OR/AND fuzzy logic or natural language processing of clinical notes OR/AND risk factors, like indwelling 
catheters). The dots represent the sensitivities for each individual study per type of HAI, the red lines represent the average sensitivities.
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Microbiological data
The most prevalent variable included in EASS is the 
microbiological examination (present in at least one 
of the algorithms presented in 61 of the 78 articles). 
It is a crucial variable in algorithms for surveillance of 
BSI. Good sensitivities have been achieved using the 
results of microbiological examinations as the sole 
variable (Figure 3). In other types of HAI (UTI, SSI and 
LRTI) the sensitivity of algorithms that use microbio-
logical examination alone is lower. As a consequence 
of the definitions used as ‘gold standard’, the micro-
biological examination variable is often combined 
with clinical characteristics (Figure 3). Although the 
microbiology variable seems straightforward, it can 
mean several things, i.e. the presence of bacteriologi-
cal examinations, which use either culture, serological 
or molecular techniques or all of these. The presence 
and quality of the microbiological examination highly 
depends on the availability of the service – often lack-
ing in low income settings –, and on the adherence to 
diagnostic protocols. Finally, a negative microbiologi-
cal examination does not unequivocally exclude the 
presence an infectious disease.
Chemistry
Clinical chemistry evaluation of biomarkers for infec-
tions are routinely performed in most clinical settings. 
Leukocyte counts and C-reactive protein (CRP) are the 
variables of choice in different algorithms made for HAI 
surveillance, but they are always, in all 19 of 78 studies 
that use this variable, used in combination with other 
parameters [3,26,35,36,39,42,43,45,46,49,56,64,65,7
0,72,73,75,82,87].
Antibiotics
Following microbiological data, antibiotic prescriptions 
data are the second most used variable in EASS algo-
rithms (38 of 78 studies) and, when not combined with 
microbiological data, most often found in combination 
with ICD coding [12,16,36,56].
International Classification of Diseases
The sensitivity of ICD-coding (9th or 10th edi-
tion) is generally low, in five of the seven studies 
that use this as the sole variable of the algorithm 
[11,39,54,70,77,78,83]. The two studies with sensi-
tivities of 0.86 and 0.97 focused on SSI after coronary 
artery bypass graft surgery and total joint replacement 
[39,54]. ICD-coding has not been studied for all types 
of HAI surveillance nor for LRTI surveillance (Figure 2).
Electronically assisted surveillance system per type of 
healthcare-associated infection
Bloodstream infections (including central line 
associated)
Twenty-three publications (Table 3) described the per-
formance of an EASS to detect BSI. Sensitivity ranged 
from 0.32 to 1.0, specificity from 0.37 to 1.
In 2017, Gubbels et al. presented the results of an 
automated nationwide survey, using the Danish 
Microbiology Database and the Danish National Patient 
Registry. National trends showed an increase in hos-
pital-acquired bacteraemia (HAIBA) cases between 
2010 and 2014. Although comparison of their HAIBA 
algorithm with the results of point prevalence sur-
veys showed a sensitivity of 0.36 they concluded 
that given the many advantages of automated sur-
veillance, the HAIBA algorithm allows monitoring of 
HAIBA across the healthcare system, supports pri-
oritising preventive measures, and holds promise 
for evaluating interventions [80]. Another approach 
to automated surveillance of BSI is the reuse of the 
ICD-coding system. Unfortunately the performance to 
detect BSI in the paediatric ICU was shown to be very 
poor (sensitivity of 0.32), as Bond et al. showed [78]. 
In contrast, one adult ICU-tailored algorithm showed 
excellent performance characteristics (sensitivity and 
specificity of 1) [28]. The study was conducted at the 
14-bed medical ICU (MICU) and the 22-bed surgical 
ICU (SICU) of Ghent University Hospital (1,050 beds), 
where Computer-based Surveillance and Alerting of 
infections Antimicrobial Resistance and Antibiotic con-
sumption (COSARA) software has been available since 
2010. With COSARA, all infection-related data from 
the various electronic patient records are integrated 
and presented to the treating ICU physician by means 
of a continuously updated clinical dash-board. This 
includes a graphical display of current and past antibi-
otic treatments as a timeline, and provides direct links 
to a real-time copy of the various source records. The 
graphical interface allows episodes of antibiotic treat-
ment to be labelled according to a predefined list of 
indications and diagnoses, and linked with microbio-
logical culture results [28]. Surveillance for CLABSIs by 
infection control practitioners is often limited to ICUs. 
Woeltje et al. applied an automated surveillance sys-
tem for CLABSI outside the ICU. Is this study they eval-
uated the performance of 12 different rule sets for the 
detection of CLABSI. The best-performing rule set had 
an overall sensitivity of 0.95, specificity of 0.97, posi-
tive predictive value of 0.90, and negative predictive 
value of 0.99 compared with intensive manual surveil-
lance. The method offered the possibility of performing 
acceptably good surveillance in areas where resources 
do not allow for traditional manual surveillance [76]. 
This hospital-wide approach generally results in lower 
sensitivities [4,13,63]. However, Tseng et al. showed 
their hospital-wide EASS system performed very well 
in a 2,200-bed teaching hospital, with regard to sensi-
tivity (0.98), specificity (0.99), positive predictive value 
(0.96), and negative predictive value (1) compared with 
their reference standard, which, remarkably, was a 
continuous manual, hospital-wide surveillance for BSI, 
including CLABSI, operating since 1981 [67].
Lower respiratory tract infections (including ventilator-
associated pneumonia)
Sixteen publications (Table 4) from 2005 to 2018 pre-
sented the performance of an EASS to detect LRTIs, 
including hospital-acquired pneumonia (HAP), mostly 
VAP. Sensitivity ranged from 0.33 to 1.0 and specificity 
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from 0.58 to 1.0. The majority of the studies (14/16) 
addressed the performance of an EASS to detect VAP in 
an ICU setting, including two neonatal ICUs. Because of 
the complexity of the definitions, ventilator-associated 
events (VAE), ventilator-associated conditions (VAC) 
or VAP, comparing the studies’ methods and results is 
difficult.
Urinary tract infections (including catheter-associated 
urinary tract infections)
UTI is one of the ‘big four’ and is third, behind SSI and 
LRTI, in HAI prevalence in the Netherlands (2017) [94]. 
Internationally 18 publications (Table 5) presented the 
performance of an EASS to detect catheter-associated 
(CA)UTI. Reported sensitivities ranged from 0.02 to 1.0, 
whereas specificities ranged from 0.59 to 1.0. There are 
several reasons for the low sensitivity described in the 
report by Condell et al., including laboratory results 
being unavailable at the time of the survey, the results 
considered clinically irrelevant by the surveyor due to 
an indwelling urinary catheter or lack of clinical signs 
of infection. UTIs being considered hospital-acquired in 
‘the gold standard’ even though the first sample was 
taken within 48 hours of admission also compromised 
Table 3
Performance characteristics of electronically assisted surveillance systems for surveillance of bloodstream infection 
(including central line associated infection) (n = 23 studies)
Ref. First author Algorithm category Year of publication Sensitivity Specificity PPV NPV Accuracy
a Concordance
[68] Tseng Other 2013 NA NA NA NA 0.94 NA
[82] Leal Microbiology 2016 NA NA NA NA NA 0.97
[18] Bouzbid Other 2011 1 0.37 0.1 1 NA NA
[28] De Bus Other 2014 1 1 NA NA NA NA
[58] Redder
Microbiology 
 
+ antibiotics
2015 1 1 0.88 1 NA NA
[73] Venable Microbiology 2013 1 0.92 NA NA NA NA
[67] Tseng Other 2015 0.98 0.99 0.96 1 NA NA
[75] Woeltje
Microbiology 
 
 + antibiotics
2008 0.97 0.44 0.15 0.99 NA NA
[66] Trick Microbiology 2004 0.97 0.73 NA NA NA NA
[76] Woeltje
Microbiology 
 
 + antibiotics
2011 0.95 0.98 0.9 0.99 NA NA
[40] Kaiser Other 2014 0.92 1 1 1 NA NA
[63] Streefkerk
Microbiology 
 
 + antibiotics 
 
 + chemistry
2014 0.91 NA NA NA NA NA
[59] Ridgway Microbiology 2016 0.89 1 NA 1 NA NA
[17] Bouam Microbiology 2003 0.89 0.75 0.63 0.93 NA NA
[35] Henry Other 2013 0.88 0.92 NA NA NA NA
[4] Brossette Microbiology 2006 0.86 1 NA NA NA NA
[32] Graham Microbiology 2004 0,84 0.99 0.84 0.99 NA NA
[86] Streefkerk
Microbiology 
 
 + antibiotics 
 
  + chemistry
2016 0.83 NA NA NA NA NA
[14] Bellini Microbiology 2007 0.78 0.93 NA NA NA NA
[61] Stamm Microbiology 2012 0.78 NA 0.5 NA NA NA
[13] Bearman Other 2010 0.69 0.88 0.05 NA NA NA
[80] Gubbels Microbiology 2017 0.36 0.99 NA NA NA NA
[78] Bond ICD codes 2016 0.32 NA NA NA NA NA
ICD: International Classification of Diseases; HAI: healthcare-associated infection; NA: data not available; NPV: negative predictive value; 
PPV: positive predictive value; ref.: reference.
a Accuracy is calculated as: (TP+TN) / (TP+TN+FP+FN) where TP is the true positive (i.e. the number of individuals correctly identified as 
positive for a given HAI), FP is the false positive (i.e. the number of individuals incorrectly identified as positive for the given HAI), TN is the 
true negative (i.e. the number of individuals correctly identified as negative for the given HAI) and FN is the false negative (i.e. the number of 
individuals incorrectly identified as negative for the given HAI).
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sensitivity [79]. ICD-10 codes for UTI surveillance were 
shown to perform poorly (sensitivity 0.02) and were 
only studied in one study [83]. On the other hand a 
urine culture as the only parameter proved to perform 
well [38,50].
Surgical site infections
Not surprisingly, the majority of publications, 29 in 
total, presented the performance of an EASS to detect 
SSI (Table 6). Different fields of surgery are targeted, 
from neurosurgery to total hip replacements and dif-
ferent algorithms with sensitivities ranging from 0.02 
to 1.0 and specificities ranging from 0.59 to 1.0 have 
been explored. Administrative data (ICD-9 admission 
and discharge coding and claims data) generally per-
formed poorly when used as the only variable for case 
finding [37,46,54,70,77].
Interestingly a Michigan study by Baker et al. showed 
a 0.89 sensitivity for ICD-9 codes when these were 
solely used to determine post-caesarean section 
SSIs. Combining ICD-9 with specific post-operative 
antibiotics increased the specificity of the case find-
ing algorithm to 0.95 and resulted in a ca 90% work-
load reduction [12]. Fifteen years later in Denmark, 
comparable performance characteristics were found 
for in-hospital and post-discharge surveillance of post-
caesarean section SSIs using ICD-10 discharge codes 
in combination with relevant antibiotics and culture 
data [49].
Adding microbiology and radiographic data (culture, 
magnetic resonance imaging ordered) as variables of 
case finding algorithms resulted in a positive predic-
tive value of 0.97, although at the cost of sensitivity 
(0.48) [19]. A text mining algorithm as presented by 
Michelson et al. found all of the 22 SSIs detected by 
traditional hospital-based surveillance, along with an 
additional 37 SSIs not detected by traditional surveil-
lance [53].
Quality and performance
The quality of the 78 studies included in this review 
varied from an overall quality score of 5 to 26. Likewise, 
the overall performance score of the EASS developed 
and used for HAI surveillance varied widely among the 
studies, with overall performance scores ranging from 
a low 0.2 to the maximum of 1.0. When quality of study 
design was plotted against the level of performance of 
the EASS there seemed to be a, albeit weak, negative 
Table 4
Performance characteristics of electronically assisted surveillance systems for surveillance of lower respiratory tract 
infection (including ventilator associated infection) (n = 16 studies)
Ref. First author Algorithm category Year of publication Sensitivity Specificity PPV NPV
[51] Mann Other 2015 1 1 1 1
[81] Hebert
Microbiology 
 
+ antibiotics 
 
 + chemistry
2018 1 NA NA NA
[18] Bouzbid Other 2011 0.99 0.58 0.22 1
[26] Claridge Other 2009 0.97 1 NA NA
[42] Klompas Other 2008 0.95 1 NA NA
[86] Streefkerk
Microbiology 
 
 + antibiotics 
 
 + chemistry
2016 0.94 NA NA NA
[62] Stevens Other 2014 0.94 NA 1 NA
[55] Nuckchady Other 2015 0.93 0.99 0.95 0.98
[40] Kaiser Other 2014 0.92 1 1 1
[63] Streefkerk
Microbiology 
 
 + antibiotics 
 
 + chemistry
2014 0.92 NA NA NA
[35] FitzHenry Other 2013 0.8 0.9 NA NA
[28] De Bus Other 2014 0.77 0.99 NA NA
[33] Haas Other 2005 0.71 0.95 0.08 1
[52] Mendonca Other 2005 0.71 0.99 0.075 NA
[61] Stamm Microbiology 2012 0.54 NA 0.25 NA
[43] Klouwenberg Other 2014 0.33 NA 0.25 NA
NA: data not available; NPV: negative predictive value; PPV: positive predictive value; ref.: reference.
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correlation, suggesting that the best designed stud-
ies tended to yield lower performance scores or vice 
versa, that the studies reporting very high performance 
scores of their EASS were generally less well designed 
(Figure 4).
Based on this view of the overall quality and perfor-
mance score we selected the 10 best studies (labelled 
in the figure) that showed the highest overall quality 
scores and also yielded a high overall performance 
score ≥ 0.85 (Figure 4  upper right quadrant). They, 
together, constitute a reference or can be considered 
a benchmark, for EASS development. Interestingly 
all these studies were reported only recently (2013–
2016), indicating that some progress has been made in 
designing and evaluating EASS (Table 7).
Interestingly, the majority of the 10 best EASS pre-
sented in  Table 7  used a two-step procedure, first 
a selection step based on an automated algorithm, 
followed by step in which a confirmatory assessment 
of the selected cases by the ICP is performed. The 
monitoring of nosocomial infections (MONI) software 
on the ICU, the MONI-ICU system [27], however, 
achieved a high specificity of the EASS for all types of 
HAI based on an automated selection step only. This 
was achieved in a university hospital ICU by building 
a system consisting of fuzzy logic sets, which used a 
rich dataset including clinical, laboratory and nursing 
data from the patient data management systems in 
operation at the ICU wards on a daily basis. Du et al. 
[3] showed that based on a dataset including microbi-
ology, clinical chemistry, antibiotics prescriptions and 
clinical characteristics, it is possible to perform con-
tinuous hospital-wide all type HAI surveillance with an 
EASS. Of note, they stated that their hospital has the 
most advanced computer information system in China, 
including an integrated hospital information system 
(IHIS). When documented in the electronic patient 
record clinical characteristics, like body temperature or 
Table 5
Performance characteristics of electronically assisted surveillance systems for surveillance of urinary tract infection 
(including catheter-associated infection) (n = 18 studies)
Ref. First author Algorithm category Year of publication Sensitivity Specificity PPV NPV
[50] Lo
Microbiology 
 
 + antibiotics
2013 1 0.95 NA NA
[38] Hsu
Microbiology 
 
 + antibiotics 
 
 + chemistry
2015 1 1 NA NA
[73] Venable Microbiology 2013 1 0.97 NA NA
[18] Bouzbid Other 2011 0.98 0.59 0.183 1
[17] Bouam Microbiology 2003 0.95 1 1 0.95
[4] Brossette Microbiology 2006 0.95 1 NA NA
[35] Henry Other 2013 0.95 0.8 NA NA
[63] Streefkerk
Microbiology 
 
 + antibiotics 
 
 + chemistry
2014 0.87 NA NA NA
[25] Choudhuri Other 2011 0.86 0.94 0.85 0.94
[28] De Bus Other 2014 0.8 0.99 NA NA
[74] Wald Other 2014 0.8 0.99 0.69 0.99
[58] Redder
Microbiology 
 
 + antibiotics
2015 0.78 0.93 0.88 0.87
[86] Streefkerk
Microbiology 
 
 + antibiotics 
 
 + chemistry
2016 0.67 NA NA NA
[20] Branch-Elliman Other 2015 0.65 1 0.54 1
[62] Stamm Microbiology 2012 0.61 NA 0.47 NA
[65] Tanushi Other 2014 0.6 0.99 NA 0.98
[79] Condell Other 2016 0.5 0.94 NA NA
[83] Marra ICD codes 2017 0.02 NA NA NA
ICD: International Classification of Diseases; NA: data not available; NPV: negative predictive value; PPV: positive predictive value; ref.: 
reference.
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Table 6
Performance characteristics of electronically assisted surveillance systems for surveillance of surgical site infection (n = 29 
studies)
Ref. First author Algorithm category Year of publication Sensitivity Specificity PPV NPV Accuracy
[11] Apte ICD codes 2011 0.86 NA NA NA NA
[12] Baker Other 1995 0.89 0.95 0.53 NA NA
[16] Bolon Other 2009 1 NA 0.07 1 NA
[19] Branch-Elliman Other 2014 0.97 0.98 NA NA NA
[4] Brossette Microbiology 2006 1 0.6 NA NA NA
[23] Chalfine Microbiology 2005 0.84 1 NA NA NA
[31] Gerbier-Colomban Other 2012 0.92 0.86 NA NA NA
[34] Hautemanière Other 2013 0.54 0.95 0.74 0.88 NA
[35] Henry Other 2013 0.77 0.63 NA NA NA
[37] Hollenbeak Microbiology 2011 0.2 0.96 NA NA 0.89
[39] Inacio ICD codes 2011 0.97 0.92 NA NA NA
[41] King Other 2014 0.9 0.94 NA NA NA
[44] Knepper Other 2013 1 0.88 NA NA NA
[45] Knepper Other 2014 0.94 0.88 NA NA NA
[46] Kulaylat Microbiology 2016 0.37 1 0.72 0.99 NA
[47] Leclere Other 2014 0.90 0.98 0.25 1 NA
[49] Leth Other 2010 0.90 0.98 0.54 1 NA
[53] Michelson Other 2014 1 NA NA NA NA
[54] Moro ICD codes 2004 0.21 NA NA NA NA
[63] Streefkerk
Microbiology 
 
 + antibiotics 
 
 + chemistry
2014 0.91 NA NA NA NA
[69] van Mourik
Microbiology 
 
 + antibiotics 
 
 + chemistry
2011 0.99 0.88 0.57 1 NA
[70] van Mourik ICD codes 2013 0.32 NA 0.35 NA NA
[71] van Mourik
Microbiology 
 
 + antibiotics 
 
 + chemistry
2012 1 NA 0.59 NA NA
[72] van Mourik
Microbiology 
 
 + antibiotics 
 
 + chemistry
2015 0.97 NA 0.47 NA NA
[77] Yu ICD codes 2014 0.35 0.97 0.19 0.99 NA
[56] Perdiz Other 2016 0.88 1 1 1 NA
[86] Streefkerk
Microbiology 
 
 + antibiotics 
 
 + chemistry
2016 1 NA NA NA NA
[84] Pindijck Other 2018 0.92 0.57 NA NA NA
[85] Sips
Microbiology 
 
 + antibiotics
2017 1 NA 0.68 NA NA
ICD: International Classification of Diseases; NA: data not available; NPV: negative predictive value; PPV: positive predictive value; ref.: 
reference.
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the presence of invasive devices, improve sensitivity 
and specificity of EASS. The data in  Table 7  suggests 
that richer datasets lead to better performing EASS. 
Remarkably only five articles presented the time 
reduction achieved by using an EASS.
Conclusions
Ideally, surveillance of HAIs comprises all depart-
ments, medical specialties and includes all types of 
HAI, because only then fully informed decisions can be 
made to prioritise and structurally address the relevant 
infection issues of the particular healthcare setting. 
In this review of the literature we found that very few 
EASS are ‘all types, hospital-wide’, although perfor-
mance characteristics of these systems are generally 
good. The absence of traditional hospital-wide surveil-
lance of HAI by the infection preventionist, which can 
be used as gold standard for validation can be one 
cause. On the other hand, the fact that most studies 
have been performed in an ICU setting implicates that 
hospital-wide electronic health records or data ware-
houses are still not ready to be used for decision sup-
port and surveillance.
Because of limited resources and the labour intensity 
of manual surveillance systems, efforts have been 
made to improve the efficiency of HAI surveillance 
by applying information technologies to query elec-
tronic datasets. However, we found that in literature, 
less than 20% of the studies present the actual time 
reduction that was achieved by introducing an EASS 
for HAI. Oher quality indicators, most importantly 
using different populations for development, testing 
and validation, are also lacking. Although sensitivity of 
EASS is generally high the specificity is variable, need-
ing a confirmatory computer-assisted assessment by 
the infection preventionist and decision support. The 
parameters used in the algorithms studied vary consid-
erably, do not have a standardised format nor are read-
ily available in all hospital settings around the globe.
Although PRISMA guidelines were followed, this review 
has some limitations. Only English literature and no 
grey literature were considered for inclusion. The scor-
ing system that was developed for and used in this 
study to assess the quality of the included studies’ 
design was not prior validated.
In summary, thus far computer-assisted surveillance of 
HAI has not reached a mature stage, it is yet to be used 
routinely in most healthcare settings; we are learning, 
but we have not yet mastered the art. Although pro-
gress is being made towards a digital infrastructure for 
the learning health system [95], it is, in our opinion, 
not likely that EASS of HAI will be implemented globally 
within the next decade. A data-driven and decision-
supported healthcare system, including infection con-
trol surveillance, requires next generation electronic 
health records systems [96], clinical ownership and a 
good and close working relationship between infection 
control professionals and medical information special-
ists [97].
We recommend that future studies on the development 
and implementation of EASS of HAI focus on thorough 
validation, reproducibility in different hospital-settings 
of the algorithm and standardised datasets and present 
detailed information on efficiency. This information, 
together with the continuous focus on the importance 
of surveillance of HAI, is needed to convince health-
care providers, professionals and boards of directors, 
to invest in EASS, in the future of infection control.
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